CHRNA7 and cancer: It is important to mention that, for CRC, we have to make a clear distinction between inflammation-associated cancers in patients with inflammatory conditions, such as inflammatory bowel disease, and cancers developed following the adenoma-adenocarcinoma sequence, since the role of α7nAChR in these two types of cancers may be different.